---
title: "Creative Medical Technology Holdings issues mid-year update press release"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291420127.md"
description: "Creative Medical Technology Holdings issued a mid-2026 update highlighting progress in its regenerative medicine and AI biodefense pipelines. Key developments include positive interim data for Olastrocel (CELZ-201) in chronic lower back pain, with FDA clearance for an expanded cohort. Additionally, the Ultrasome knee osteoarthritis pilot met its primary endpoint, showing 93% clinically meaningful improvement, while Project PHOENIX has launched nationwide AI-enabled virtual data collection targeting veterans."
datetime: "2026-07-01T13:03:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291420127.md)
  - [en](https://longbridge.com/en/news/291420127.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291420127.md)
generator: "portal-rs"
---

# Creative Medical Technology Holdings issues mid-year update press release

-   Creative Medical Technology Holdings issued a mid-year 2026 update, citing progress across its regenerative medicine pipeline and AI-enabled biodefense platform. \* Olastrocel (CELZ-201) posted positive interim 180-day ADAPT data in chronic lower back pain; FDA cleared an expanded cohort now over 85% enrolled. \* Ultrasome knee osteoarthritis pilot hit its primary endpoint with 93% showing clinically meaningful improvement; next-stage multi-center study planning underway. \* Project PHOENIX moved into nationwide AI-enabled virtual data collection targeting at least 1,000 veterans to build the Toxic Exposure Atlas. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Creative Medical Technology Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607010900PRIMZONEFULLFEED9755352) on July 01, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [CELZ.US](https://longbridge.com/en/quote/CELZ.US.md)

## Related News & Research

- [Creative Medical Technology Holdings stockholders approved increase in authorized common shares to 100 million](https://longbridge.com/en/news/297556623.md)
- [Parents learned AI was in their kids' classrooms. Then they took it to Mamdani's office.](https://longbridge.com/en/news/298031438.md)
- [How can future doctors blend clinical rigour with AI fluency and empathy?](https://longbridge.com/en/news/298113191.md)
- [Global PR Agency, Genius PR, Rebrands to Reflect Growth Across Crypto, AI, and O-1 and EB-1 Visa PR](https://longbridge.com/en/news/297960123.md)
- [HINDUNILVR: Volume-led growth, premiumisation, and digital innovation drive future value creation](https://longbridge.com/en/news/297993125.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**